Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Jan 18;91(2):787-91.
doi: 10.1073/pnas.91.2.787.

Pineal control of aging: effect of melatonin and pineal grafting on aging mice

Affiliations

Pineal control of aging: effect of melatonin and pineal grafting on aging mice

W Pierpaoli et al. Proc Natl Acad Sci U S A. .

Abstract

Dark-cycle, night administration of the pineal hormone melatonin in drinking water to aging mice (15 months of age) prolongs survival of BALB/c females from 23.8 to 28.1 months and preserves aspects of their youthful state. Similar results were seen in New Zealand Black females beginning at 5 months and C57BL/6 males beginning at 19 months. As melatonin is produced in circadian fashion from the pineal, we grafted pineals from young 3- to 4-month-old donors into the thymus of 20-month-old syngeneic C57BL/6 male recipients, and a 12% increase in survival was induced. Prolongation of survival was also seen on pineal transplant to the thymus in C57BL/6, BALB/cJ, and hybrid female mice at 16, 19, and 22 months. In all studies, the endogenous pineal of grafted mice was left in situ. Pineal grafted aged mice display a remarkable maintenance of thymic structure and cellularity. Preservation of T-cell-mediated function, despite age, as measured by response to oxazolone is seen. Other evidence suggests that melatonin and/or pineal-related factors could produce their effects through an influence on thyroid function. These data indicate that pineal influences have a place in the physiologic regulation of aging.

PubMed Disclaimer

References

    1. Anat Rec. 1981 Feb;199(2):239-47 - PubMed
    1. Int J Immunopharmacol. 1989;11(5):567-73 - PubMed
    1. Experientia. 1990 Aug 15;46(8):860-2 - PubMed
    1. Acta Oncol. 1990;29(6):775-6 - PubMed
    1. Ann N Y Acad Sci. 1991;621:291-313 - PubMed

MeSH terms